Financials

688505 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM operating, investing, and financing activities

688505 free cash flow for Q4 24 is 18.9 M CNY. For 2024, 688505 free cash flow was -57.44 M CNY and operating cash flow was -14.77 M CNY.

Q1 '12

Q2 '12

Q3 '12

Q4 '12

Q1 '13

Q2 '13

Q3 '13

Q2 '14

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CNY